Abstract
Regenerative medicine using cell therapy offers a promising strategy for recovery of damaged myocardium. C-kit-positive cardiac stem cells (CSCs) alleviate myocardial dysfunction after ischemic injury. Use of human cells in animals generally requires immuno-suppression limiting the duration of
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
